2019 Spectrum SPADA Pilot Grants
Program Overview:
SPADA, the Stanford Predictives and Diagnostics Accelerator, assists interdisciplinary innovations in research, development, and deployment of technologies that improve human health through disease prediction and/or diagnosis. The defined scope of SPADA includes projects with a goal of diagnosing and/or predicting the onset, course, worsening, or complications of disease, and prolonging health.
Spectrum SPADA Pilot Grants must have the objective of translating discoveries into novel Predictives and Diagnostics products that address unmet medical needs. Emphasis will be placed on technologies that have the potential to advance rapidly into clinical care through commercialization or other pathways.
Proposals should specifically address any or all of the following, as much as feasible:
- size and scope of unmet need
- drawbacks of current options
- regulatory pathway
- intellectual property landscape and freedom to operate
Deadline: Friday, December 21st, 2019, 6 p.m.
Institutional representatives: not applicable. Because this is an internal Stanford funding opportunity you do not have to submit your applications through your RPM in RMG or your CGO in OSR for their approval.
Amount of Funding:
Typical grants range between $15,000 and $50,000 per year and depend on the individual proposal. Awards will be granted for the period from April 1, 2019 through March 31, 2020.
Areas of Interest:
- Translating discoveries into novel Predictives and Diagnostics products that address unmet medical needs
Project Selection:
Proposals will be reviewed by a selection committee composed of Stanford faculty and industry experts. Based on the compiled rankings, finalists will be invited to present an oral pitch to the review panel in late February, 2019. Proposals selected for awards will be notified early March, 2019.
Program Mission:
Spectrum offers pilot grants for accelerating clinical and translational research in biomedical and health-related areas. The Spectrum SPADA Program has two major goals:
- to stimulate innovative clinical and translational research and
- to encourage collaborative, transdisciplinary work.
Our primary expectation is that these early-stage translational projects will lead to additional research, external support, information dissemination and most important, will develop into longer-term, comprehensive projects. We encourage transdisciplinary collaborations, but this is not a requirement for funding.
Open to Stanford faculty with PI eligibility (with UTL, MCL, NTLR faculty appointments.), Clinical Educator (CE) faculty, clinical instructors, instructors, graduate students and post-doctoral scholars (clinical and non-clinical) are required to include a PI-eligible faculty member as co-PI on the application.
Allowable expenditures include investigator’s salary, research personnel salaries, travel (if project-related) and project supplies. These grants do not include indirect cost expenses. Capital equipment costing more than $5,000, intellectual property services, and food (certain exceptions apply) are unallowable expenses.
